T2 Biosystems was featured in the World Antimicrobial Resistance Congress keynote presentation session. The plenary session highlighted the ability of the FDA-cleared T2Bacteria and T2Candida Panels to provide faster targeted therapy and support the critical aims of improved patient care and better antimicrobial stewardship.
- Infectious disease expert and T2 customer Cornelius J. Clancy, M.D., University of Pittsburgh
- Mary Millard, M. Ed., Patient Advocate, Sepsis Survivor
- Thomas J. Lowery, Ph.D., Chief Scientific Officer, T2 Biosystems